These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32542790)

  • 1. Dosing Recommendations for Pediatric Patients With Renal Impairment.
    Al-Khouja A; Park K; Anderson DJC; Young C; Wang J; Huang SM; Khurana M; Burckart GJ
    J Clin Pharmacol; 2020 Dec; 60(12):1551-1560. PubMed ID: 32542790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strength of evidence for labeled dosing recommendations in renal impairment.
    Gagne JJ; Khan NF; Raj TS; Patel LR; Choudhry NK
    Clin Trials; 2017 Apr; 14(2):219-221. PubMed ID: 27780884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020.
    Green FG; Park K; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S28-S35. PubMed ID: 34185898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient impact of automated glomerular filtration rate reporting on drug dosing for hospitalized older adults with concealed renal insufficiency.
    Kalender-Rich JL; Mahnken JD; Wetmore JB; Rigler SK
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):320-7. PubMed ID: 21920825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
    Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug dosage adjustment of patients with impaired renal function at hospital discharge in a teaching hospital.
    Sah SK; Wanakamanee U; Lerkiatbundit S; Regmi BM
    J Nepal Health Res Counc; 2014 Jan; 12(26):54-8. PubMed ID: 25574986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary.
    Wang J; van den Anker JN; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S13-S21. PubMed ID: 34185909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?
    Khanal A; Castelino RL; Peterson GM; Jose MD
    Intern Med J; 2014 Jan; 44(1):77-85. PubMed ID: 24112311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.
    Wang B; Canestaro WJ; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1938-44. PubMed ID: 25317785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Impairment in Pediatric Patients: Current Approaches to Drug Dosing.
    Khurana M
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S161-S164. PubMed ID: 34185911
    [No Abstract]   [Full Text] [Related]  

  • 11. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
    Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
    Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act: What can the obstetric community learn from the pediatric experience?
    Ren Z; Zajicek A
    Semin Perinatol; 2015 Nov; 39(7):530-1. PubMed ID: 26455383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United States.
    Song YK; Han N; Burckart GJ; Oh JM
    Clin Pharmacol Ther; 2020 Mar; 107(3):530-540. PubMed ID: 31544241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Swiss Database for dosing medicinal products in pediatrics.
    Tilen R; Panis D; Aeschbacher S; Sabine T; Meyer Zu Schwabedissen HE; Berger C
    Eur J Pediatr; 2022 Mar; 181(3):1221-1231. PubMed ID: 34739591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Canadian general pediatric dosing publications.
    Dayneka N
    Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can de facto dosing practices bridge the knowledge gap in pediatric medication recommendations?
    Scheufele EL; Dubey A
    AMIA Annu Symp Proc; 2009 Nov; 2009():573-7. PubMed ID: 20351920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.
    Khanal A; Peterson GM; Castelino RL; Jose MD
    Drugs Aging; 2015 May; 32(5):391-400. PubMed ID: 25925940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate Medication in Non-Hospitalized Patients With Renal Insufficiency: A Systematic Review.
    Dörks M; Allers K; Schmiemann G; Herget-Rosenthal S; Hoffmann F
    J Am Geriatr Soc; 2017 Apr; 65(4):853-862. PubMed ID: 28240771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.